Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Dec;36(12):2639–2644. doi: 10.1128/aac.36.12.2639

Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy.

J A Korvick 1, C S Bryan 1, B Farber 1, T R Beam Jr 1, L Schenfeld 1, R R Muder 1, D Weinbaum 1, R Lumish 1, D N Gerding 1, M M Wagener 1, et al.
PMCID: PMC245520  PMID: 1482131

Abstract

Combination antimicrobial agent therapy has been advocated for treatment of gram-negative bacteremia, including that caused by Klebsiella spp. We performed a prospective, observational, 10-hospital collaborative study to evaluate the efficacy of antibiotic combination therapy versus that of monotherapy for 230 consecutive patients with Klebsiella bacteremia. The species involved were K. pneumoniae (82%), K. oxytoca (15%), and K. ozaenae (0.4%). Of the bacteremias, 26% were polymicrobial in nature. A total of 53% of cases were nosocomial infections. The most common portals were the urinary tract (28%), biliary tract (12%), lung (10%), and abdomen (9%). Some 49 and 51% of the patients had received monotherapy and antibiotic combination therapy (beta-lactam plus aminoglycoside), respectively; 14-day mortalities in the two groups were 20 and 18%, respectively. However, for the subgroup of patients who experienced hypotension within 72 h prior to or on the day of the positive blood culture, those patients who received combination therapy experienced significantly lower mortality (24%) than did those who received monotherapy (50%). We conclude that monotherapy with an antibiotic that is active in vitro against Klebsiella (beta-lactam or aminoglycoside) is sufficient therapy for less severely ill patients (immunocompetent, urinary tract portal, mentally alert, normal vital signs). On the other hand, for severely ill patients who experience hypotension, antibiotic combination therapy with a beta-lactam and an aminoglycoside agent is preferred.

Full text

PDF
2641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Elting L. S., Rodriquez S., Hernandez M. Klebsiella bacteremia. A 10-year review in a cancer institution. Cancer. 1989 Dec 1;64(11):2368–2376. doi: 10.1002/1097-0142(19891201)64:11<2368::aid-cncr2820641129>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  2. Bonadio W. A. Klebsiella pneumoniae bacteremia in children. Fifty-seven cases in 10 years. Am J Dis Child. 1989 Sep;143(9):1061–1063. doi: 10.1001/archpedi.1989.02150210095025. [DOI] [PubMed] [Google Scholar]
  3. Chow J. W., Fine M. J., Shlaes D. M., Quinn J. P., Hooper D. C., Johnson M. P., Ramphal R., Wagener M. M., Miyashiro D. K., Yu V. L. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991 Oct 15;115(8):585–590. doi: 10.7326/0003-4819-115-8-585. [DOI] [PubMed] [Google Scholar]
  4. Feldman C., Smith C., Levy H., Ginsburg P., Miller S. D., Koornhof H. J. Klebsiella pneumoniae bacteraemia at an urban general hospital. J Infect. 1990 Jan;20(1):21–31. doi: 10.1016/s0163-4453(90)92258-m. [DOI] [PubMed] [Google Scholar]
  5. García de la Torre M., Romero-Vivas J., Martínez-Beltrán J., Guerrero A., Meseguer M., Bouza E. Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis. 1985 Mar-Apr;7(2):143–150. doi: 10.1093/clinids/7.2.143. [DOI] [PubMed] [Google Scholar]
  6. Haddy R. I., Lee M., 3rd, Sangal S. P., Walbroehl G. S., Hambrick C. S., Sarti G. M. Klebsiella pneumoniae bacteremia in the community hospital. J Fam Pract. 1989 Jun;28(6):686–690. [PubMed] [Google Scholar]
  7. Hilf M., Yu V. L., Sharp J., Zuravleff J. J., Korvick J. A., Muder R. R. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989 Nov;87(5):540–546. doi: 10.1016/s0002-9343(89)80611-4. [DOI] [PubMed] [Google Scholar]
  8. Korvick J. A., Peacock J. E., Jr, Muder R. R., Wheeler R. R., Yu V. L. Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol. Antimicrob Agents Chemother. 1992 Mar;36(3):620–625. doi: 10.1128/aac.36.3.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Montgomerie J. Z., Ota J. K. Klebsiella bacteremia. Arch Intern Med. 1980 Apr;140(4):525–527. [PubMed] [Google Scholar]
  10. Terman J. W., Alford R. H., Bryant R. E. Hospital-acquired Klebsiella bacteremia. Am J Med Sci. 1972 Sep;264(3):191–196. [PubMed] [Google Scholar]
  11. Umsawasdi T., Middleman E. A., Luna M., Bodey G. P. Klebsiella bacteremia in cancer patients. Am J Med Sci. 1973 Jun;265(6):473–482. doi: 10.1097/00000441-197306000-00006. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES